IL126542A0 - Cytoprotective compounds - Google Patents
Cytoprotective compoundsInfo
- Publication number
- IL126542A0 IL126542A0 IL12654297A IL12654297A IL126542A0 IL 126542 A0 IL126542 A0 IL 126542A0 IL 12654297 A IL12654297 A IL 12654297A IL 12654297 A IL12654297 A IL 12654297A IL 126542 A0 IL126542 A0 IL 126542A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- provides compositions
- oxidation
- present
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
- C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/08—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to an acyclic carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/38—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/632,030 US5859271A (en) | 1996-04-15 | 1996-04-15 | Cytoprotective compounds |
PCT/US1997/006283 WO1997038966A2 (en) | 1996-04-15 | 1997-04-15 | Cytoprotective compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL126542A0 true IL126542A0 (en) | 1999-08-17 |
Family
ID=24533782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12654297A IL126542A0 (en) | 1996-04-15 | 1997-04-15 | Cytoprotective compounds |
Country Status (9)
Country | Link |
---|---|
US (4) | US5859271A (xx) |
EP (1) | EP0898559B1 (xx) |
JP (1) | JP2000509372A (xx) |
AT (1) | ATE245623T1 (xx) |
AU (1) | AU2731097A (xx) |
DE (1) | DE69723688T2 (xx) |
ES (1) | ES2206708T3 (xx) |
IL (1) | IL126542A0 (xx) |
WO (1) | WO1997038966A2 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859271A (en) * | 1996-04-15 | 1999-01-12 | Virginia Commonwealth University | Cytoprotective compounds |
AR023819A1 (es) * | 1999-05-03 | 2002-09-04 | Astrazeneca Ab | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
US7749539B2 (en) * | 2000-11-30 | 2010-07-06 | Efrat Biopolymers Ltd. | Polymeric formulations for drug delivery |
US20030069639A1 (en) * | 2001-04-14 | 2003-04-10 | Tom Sander | Methods and compositions for repair or replacement of joints and soft tissues |
AU2002363444B2 (en) * | 2001-11-09 | 2007-12-06 | Apt Pharmaceuticals, Inc. | A method for treating inflammatory bowel disease |
AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
AU2003245455A1 (en) * | 2002-06-13 | 2003-12-31 | Amgen Inc. | Hammerhead ribozymes |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US20110097410A1 (en) * | 2007-08-24 | 2011-04-28 | Berney Richard L | Formulations of px compounds |
WO2012119781A2 (en) * | 2011-03-10 | 2012-09-13 | University Of Geneva | Novel lipids, phospholipids, phospholipid and lipid compositions and their use |
US20130190270A1 (en) * | 2012-01-24 | 2013-07-25 | Hans W. J. Niessen | Method for Improving Vein Performance in Bypass Surgery |
CA2970617C (en) | 2014-12-18 | 2021-11-23 | Dexcel Pharma Technologies Ltd. | Alternating and semi-alternating poly(ester-anhydride) copolymers |
KR101899345B1 (ko) | 2017-02-10 | 2018-09-17 | 대봉엘에스 주식회사 | TES Trioleate를 포함하는 자외선에 대한 피부 보호용 조성물 |
CA3057766A1 (en) | 2017-03-29 | 2018-10-04 | Dexcel Pharma Technologies Ltd. | Compositions comprising biodegradable copolymers |
US20220409532A1 (en) * | 2021-06-24 | 2022-12-29 | Brian J. Huber | Composition and method for a topical treatment for venom neutralization |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4701469A (en) * | 1983-04-15 | 1987-10-20 | Roussel Uclaf | Triglycerides, process for therapeutical applications and compositions containing them |
WO1988006445A1 (en) * | 1987-02-24 | 1988-09-07 | William Regelson | Prostaglandin b1, macromolecules as anti-inflammatory agents |
US5659049A (en) * | 1988-02-18 | 1997-08-19 | Virginia Commonwealth University | Antioxidant, antiphospholipase derivatives of ricinoleic acid |
US4927658A (en) * | 1989-02-16 | 1990-05-22 | Nabisco Brands, Inc. | Tris-hydroxymethyl alkane esters as low calorie fat mimetics |
WO1991003512A1 (en) * | 1989-08-29 | 1991-03-21 | Virginia Commonwealth University | Cytoprotective fatty moiety compounds |
DE69101456T2 (de) * | 1990-01-19 | 1994-07-14 | Kao Corp | Flüssige Textilweichmacherzusammensetzung. |
GB2279948A (en) * | 1993-05-07 | 1995-01-18 | Unilever Plc | Ricinoleic acid derivative |
US5859271A (en) * | 1996-04-15 | 1999-01-12 | Virginia Commonwealth University | Cytoprotective compounds |
-
1996
- 1996-04-15 US US08/632,030 patent/US5859271A/en not_active Expired - Lifetime
-
1997
- 1997-04-15 AT AT97921204T patent/ATE245623T1/de not_active IP Right Cessation
- 1997-04-15 IL IL12654297A patent/IL126542A0/xx unknown
- 1997-04-15 WO PCT/US1997/006283 patent/WO1997038966A2/en active IP Right Grant
- 1997-04-15 JP JP9537322A patent/JP2000509372A/ja not_active Ceased
- 1997-04-15 AU AU27310/97A patent/AU2731097A/en not_active Abandoned
- 1997-04-15 ES ES97921204T patent/ES2206708T3/es not_active Expired - Lifetime
- 1997-04-15 DE DE69723688T patent/DE69723688T2/de not_active Expired - Fee Related
- 1997-04-15 EP EP97921204A patent/EP0898559B1/en not_active Expired - Lifetime
-
1998
- 1998-02-02 US US09/017,511 patent/US6020510A/en not_active Expired - Lifetime
-
2000
- 2000-01-12 US US09/481,824 patent/US6423855B2/en not_active Expired - Fee Related
-
2002
- 2002-01-10 US US10/043,641 patent/US6600059B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5859271A (en) | 1999-01-12 |
EP0898559A2 (en) | 1999-03-03 |
AU2731097A (en) | 1997-11-07 |
US6423855B2 (en) | 2002-07-23 |
DE69723688D1 (de) | 2003-08-28 |
DE69723688T2 (de) | 2004-04-15 |
US6020510A (en) | 2000-02-01 |
EP0898559B1 (en) | 2003-07-23 |
WO1997038966A3 (en) | 1998-02-26 |
WO1997038966A2 (en) | 1997-10-23 |
US20030078417A1 (en) | 2003-04-24 |
JP2000509372A (ja) | 2000-07-25 |
ATE245623T1 (de) | 2003-08-15 |
US6600059B2 (en) | 2003-07-29 |
US20020002296A1 (en) | 2002-01-03 |
ES2206708T3 (es) | 2004-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL126542A0 (en) | Cytoprotective compounds | |
EP0684830A4 (en) | THROMBOSIS INHIBITORS. | |
AP9901478A0 (en) | Compounds for the treatment of ischemia. | |
BG102811A (en) | Irreversible tyrosinekinase inhibitors | |
MXPA05012880A (es) | Inhibidores de complemento. | |
ATE199552T1 (de) | Substituierte benzolaktamverbindungen als substanz-p-antagonisten | |
DE69709727T2 (de) | Parazinon thrombin inhibitoren | |
TR199802136T2 (xx) | �MPDH enzimi inhibit�rleri olarak �re t�revleri. | |
NO942064L (no) | yminhibitorer | |
ATE298248T1 (de) | T-zell inhibierende rezeptorzusammensetzungen sowie deren verwendung | |
EP1126849A4 (en) | HETEROCYCLIC POTASSIAL CHANNEL INHIBITORS | |
TR199900310T2 (xx) | Trombin inhibit�rleri | |
DE69906345D1 (de) | Zusammensetzung zur behandlung und prävention neurologischer und pathopsychologischer krankheiten | |
WO2000037429A3 (en) | INHIBITORS OF α4β1 MEDIATED CELL ADHESION | |
WO2004049907A3 (en) | Compositions and methods for treating transplants | |
ATE232191T1 (de) | Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
NO984075D0 (no) | Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn | |
IL133179A0 (en) | Compositions and methods for inhibiting nematocyst discharge | |
AU1816500A (en) | Bleaching compositions | |
WO2003093242A3 (en) | Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade | |
WO2000021516A3 (en) | Methods for inhibiting diabetic complications | |
DK1107789T3 (da) | Sammensætninger og metoder til beskyttelse af organer, væv og celler mod beskadigelse formidlet af immunsystemet | |
TR199901307T2 (xx) | Oral skuam�z h�cre karsinomu i�in l�kotrien antagonistleri | |
MXPA03001986A (es) | Composiciones antitromboticas. |